1-3 of 3
Harald Wajant, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TNFR2 Is Expressed Preferentially By Late Differentiated CD8 T-Cells and Can be Triggered By TNFR2-Specific Ligand to Induce Cell Death of Recently Activated Antigen-Specific T Cells: A Possible Role of TNFR2 in T-Cell Deflation

Mohammad Raeiszadeh, MPhil, Matthew Verney, MSc, Charles Craddock, MDPhD, Harald Wajant, PhD, Paul Moss, MDPhD, Frederick Chen, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4352.
https://doi.org/10.1182/blood.V124.21.4352.4352
Published: 2014
Journal Articles

A Selective TNFR2 Agonist Expands Host T reg Cells in Vivo to Protect from Acute Graft-Versus-Host Disease

Andreas Beilhack, MD, Martin Chopra, PhD, Marlene Biehl, Martin Vaeth, PhD, Andreas Brandl, PhD, Jorge Amich, PhD, Janina Findeis, Ana-Laura Jordán Garrote, PhD, Christian Brede, PhD, Carina A Bäuerlein, PhD, Stefanie Schwinn, Hermann Einsele, MD, Friederike Berberich-Siebelt, PhD, Harald Wajant, PhD
Journal: Blood
Blood (2014) 124 (21): 1099.
https://doi.org/10.1182/blood.V124.21.1099.1099
Published: 2014
Journal Articles

CD40-Licensing Of Human Dendritic Cells Further Matures Tnfa-Treated Dcs But Does Not Mediate Resistance Against Inhibition Of T-Cell Proliferation By T REG

Matthias Eyrich, PhD, MD, Johannes Rachor, Marissa Blume, Isabelle Becker, Anne Stumpf, Harald Wajant, PhD, Matthias Wolfl, MD, Paul G. Schlegel, MD, Manfred Lutz, PhD
Journal: Blood
Blood (2013) 122 (21): 4726.
https://doi.org/10.1182/blood.V122.21.4726.4726
Published: 2013